Key result
Elevated cTnI occurs ~4-fold more frequently in confirmed PE versus non-PE patients.
Why the study?
Some biomarkers can aid in diagnosing pulmonary embolism and determining its severity and prognosis, but the role of cardiac troponin I levels in this context requires analysis.
Does elevated serum cardiac troponin I (cTnI) aid in the diagnosis of pulmonary embolism in patients with suspected PE?
Population
106 patients with suspected pulmonary embolism
Comparison
Elevated cardiac troponin I levels vs normal levels in patients with and without PE
Design
Observational study
Authors
Loading...
Elevated cTnI was associated with ECG/TTE changes in PE; leaves open added prognostic value beyond standard risk scores.
Observational (n=106)
Does elevated serum cardiac troponin I (cTnI) aid in the diagnosis of pulmonary embolism in patients with suspected PE?
Absolute Event Rate: 50.8% vs 11.6%
p-value: p=<0.001
Elevated serum cardiac troponin I levels have high specificity but low sensitivity for diagnosing pulmonary embolism and may indicate severe PE.
Kilinc et al. (2012) conducted an observational in Suspected pulmonary embolism (n=106). Pulmonary embolism vs. No pulmonary embolism was evaluated on High cardiac troponin I (cTnI) levels (p=<0.001). High cardiac troponin I levels were present in 50.8% of patients with confirmed pulmonary embolism compared to 11.6% of patients without pulmonary embolism (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: